{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:54:33Z","timestamp":1779353673281,"version":"3.51.4"},"reference-count":176,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RTG1949"],"award-info":[{"award-number":["RTG1949"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Human cytomegalovirus (HCMV) is a ubiquitous betaherpesvirus that frequently causes morbidity and mortality in individuals with insufficient immunity, such as transplant recipients, AIDS patients, and congenitally infected newborns. Several antiviral drugs are approved to treat HCMV infections. However, resistant HCMV mutants can arise in patients receiving long-term therapy. Additionally, side effects and the risk to cause birth defects limit the use of currently approved antivirals against HCMV. Therefore, the identification of new drug targets is of clinical relevance. Recent work identified DNA-damage binding protein 1 (DDB1) and the family of the cellular cullin (Cul) RING ubiquitin (Ub) ligases (CRLs) as host-derived factors that are relevant for the replication of human and mouse cytomegaloviruses. The first-in-class CRL inhibitory compound Pevonedistat (also called MLN4924) is currently under investigation as an anti-tumor drug in several clinical trials. Cytomegaloviruses exploit CRLs to regulate the abundance of viral proteins, and to induce the proteasomal degradation of host restriction factors involved in innate and intrinsic immunity. Accordingly, pharmacological blockade of CRL activity diminishes viral replication in cell culture. In this review, we summarize the current knowledge concerning the relevance of DDB1 and CRLs during cytomegalovirus replication and discuss chances and drawbacks of CRL inhibitory drugs as potential antiviral treatment against HCMV.<\/jats:p>","DOI":"10.3390\/ijms20071636","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T03:39:28Z","timestamp":1554262768000},"page":"1636","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Cellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses"],"prefix":"10.3390","volume":"20","author":[{"given":"Tanja","family":"Becker","sequence":"first","affiliation":[{"name":"Institute for Virology, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2733-3732","authenticated-orcid":false,"given":"Vu Thuy Khanh","family":"Le-Trilling","sequence":"additional","affiliation":[{"name":"Institute for Virology, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirko","family":"Trilling","sequence":"additional","affiliation":[{"name":"Institute for Virology, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lachmann, R., Loenenbach, A., Waterboer, T., Brenner, N., Pawlita, M., Michel, A., Thamm, M., Poethko-Muller, C., Wichmann, O., and Wiese-Posselt, M. (2018). Cytomegalovirus (CMV) seroprevalence in the adult population of Germany. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0200267"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1743-422X-5-47","article-title":"Severe cytomegalovirus infection in apparently immunocompetent patients: A systematic review","volume":"5","author":"Rafailidis","year":"2008","journal-title":"Virol. J."},{"key":"ref_4","first-page":"113","article-title":"Cytomegalovirus infection in patients with HIV infection","volume":"66","author":"Cheung","year":"1999","journal-title":"Mt. Sinai J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1093\/infdis\/jiw217","article-title":"Cytomegalovirus and HIV: A Dangerous Pas de Deux","volume":"214","author":"Gianella","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1111\/j.1600-6143.2009.02897.x","article-title":"AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplant recipients","volume":"9","author":"Humar","year":"2009","journal-title":"Am. J. Transplant."},{"key":"ref_7","first-page":"3359","article-title":"CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: A report from the Acute Leukemia Working Party of EBMT","volume":"122","author":"Labopin","year":"2013","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Cannon, M.J., and Davis, K.F. (2005). Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health, 5.","DOI":"10.1186\/1471-2458-5-70"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ypmed.2012.03.009","article-title":"Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus","volume":"54","author":"Cannon","year":"2012","journal-title":"Prev. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Plotkin, S.A., and Boppana, S.B. (2018). Vaccination against the human cytomegalovirus. Vaccine.","DOI":"10.1016\/j.vaccine.2018.02.089"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S2055-6640(20)30872-4","article-title":"Cytomegalovirus vaccines under clinical development","volume":"2","author":"Schleiss","year":"2016","journal-title":"J. Virus Erad."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e00268-17","DOI":"10.1128\/CVI.00268-17","article-title":"Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection","volume":"24","author":"Schleiss","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_13","first-page":"125","article-title":"Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169","volume":"154","author":"Chee","year":"1990","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Brizic, I., Lisnic, B., Brune, W., Hengel, H., and Jonjic, S. (2018). Cytomegalovirus Infection: Mouse Model. Curr. Protoc. Immunol.","DOI":"10.1002\/cpim.51"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15989","DOI":"10.1038\/s41598-017-16262-z","article-title":"Long-Read Sequencing of Human Cytomegalovirus Transcriptome Reveals RNA Isoforms Carrying Distinct Coding Potentials","volume":"7","author":"Balazs","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nmeth.4631","article-title":"Improved Ribo-seq enables identification of cryptic translation events","volume":"15","author":"Erhard","year":"2018","journal-title":"Nat. Methods"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"19755","DOI":"10.1073\/pnas.1115861108","article-title":"High-resolution human cytomegalovirus transcriptome","volume":"108","author":"Gatherer","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1227919","article-title":"Decoding human cytomegalovirus","volume":"338","author":"Weisburd","year":"2012","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Hodson, E.M., Ladhani, M., Webster, A.C., Strippoli, G.F., and Craig, J.C. (2013). Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD003774.pub4"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1399-0012.2008.00942.x","article-title":"Hematologic complications of anti-CMV therapy in solid organ transplant recipients","volume":"23","year":"2009","journal-title":"Clin. Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","article-title":"Antiviral drug-induced nephrotoxicity","volume":"45","author":"Izzedine","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF01968962","article-title":"In vitro and in vivo studies on the prenatal toxicity of five virustatic nucleoside analogues in comparison to aciclovir","volume":"65","author":"Klug","year":"1991","journal-title":"Arch. Toxicol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.csbj.2015.01.003","article-title":"Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients","volume":"13","author":"Gohring","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbmt.2018.09.038","article-title":"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation","volume":"25","author":"Marty","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ymthe.2017.03.023","article-title":"FDA-Approved Oligonucleotide Therapies in 2017","volume":"25","author":"Stein","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1182\/blood-2008-03-142521","article-title":"Cytomegalovirus: Time for a requiem?","volume":"111","author":"Mehta","year":"2008","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1473-3099(11)70024-X","article-title":"Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: A phase 3, double-blind, placebo-controlled, randomised trial","volume":"11","author":"Marty","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Papanicolaou, G.A., Silveira, F.P., Langston, A.A., Pereira, M.R., Avery, R.K., Uknis, M., Wijatyk, A., Wu, J., Boeckh, M., and Marty, F.M. (2018). Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study. Clin. Infect. Dis.","DOI":"10.1093\/cid\/ciy706"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1128\/AAC.01623-15","article-title":"Rapid In Vitro Evolution of Human Cytomegalovirus UL56 Mutations That Confer Letermovir Resistance","volume":"59","author":"Chou","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e2019001","DOI":"10.4084\/mjhid.2019.001","article-title":"In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation","volume":"11","author":"Frietsch","year":"2019","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e00922-18","DOI":"10.1128\/AAC.00922-18","article-title":"New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by In Vitro Exposure to Letermovir and Ganciclovir","volume":"62","author":"Chou","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Hodowanec, A.C., Pikis, A., Komatsu, T.E., Sampson, M.R., Younis, I.R., O\u2019Rear, J.J., and Singer, M.E. (2018). Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives. J. Clin. Pharmacol.","DOI":"10.1002\/jcph.1363"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2017.00029","article-title":"Canonical and Non-Canonical Aspects of JAK-STAT Signaling: Lessons from Interferons for Cytokine Responses","volume":"8","author":"Majoros","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1074-7613(00)00054-6","article-title":"Partial impairment of cytokine responses in Tyk2-deficient mice","volume":"13","author":"Karaghiosoff","year":"2000","journal-title":"Immunity"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e00296-18","DOI":"10.1128\/JVI.00296-18","article-title":"STAT2-Dependent Immune Responses Ensure Host Survival despite the Presence of a Potent Viral Antagonist","volume":"92","author":"Wohlgemuth","year":"2018","journal-title":"J. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1515\/BC.1999.087","article-title":"Activation of the transcription factor ISGF3 by interferon-gamma","volume":"380","author":"Matsumoto","year":"1999","journal-title":"Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1126\/science.288.5475.2357","article-title":"Cross talk between interferon-gamma and -alpha\/beta signaling components in caveolar membrane domains","volume":"288","author":"Takaoka","year":"2000","journal-title":"Science"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8107","DOI":"10.1093\/nar\/gkt589","article-title":"Deciphering the modulation of gene expression by type I and II interferons combining 4sU-tagging, translational arrest and in silico promoter analysis","volume":"41","author":"Trilling","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1084\/jem.20041401","article-title":"A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses","volume":"201","author":"Zimmermann","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e38867","DOI":"10.7554\/eLife.38867","article-title":"The aryl hydrocarbon receptor and interferon gamma generate antiviral states via transcriptional repression","volume":"7","author":"Kueck","year":"2018","journal-title":"Elife"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3389\/fimmu.2017.01139","article-title":"Deciphering of the Human Interferon-Regulated Proteome by Mass Spectrometry-Based Quantitative Analysis Reveals Extent and Dynamics of Protein Induction and Repression","volume":"8","author":"Megger","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3181\/00379727-125-32220","article-title":"Interferon and cytomegalovirus in vivo and in vitro","volume":"125","author":"Glasgow","year":"1967","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.biocel.2013.05.026","article-title":"Non-canonical ubiquitylation: Mechanisms and consequences","volume":"45","author":"McDowell","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/nature05902","article-title":"Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging","volume":"447","author":"Jin","year":"2007","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"23010","DOI":"10.1074\/jbc.C700111200","article-title":"UBE1L2, a novel E1 enzyme specific for ubiquitin","volume":"282","author":"Pelzer","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/cr.2016.35","article-title":"E2 enzymes: More than just middle men","volume":"26","author":"Stewart","year":"2016","journal-title":"Cell Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"re5","DOI":"10.1126\/scisignal.2002187","article-title":"The emerging role of linear ubiquitination in cell signaling","volume":"4","author":"Emmerich","year":"2011","journal-title":"Sci. Signal."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.tibs.2017.09.002","article-title":"The Ubiquitin Code in the Ubiquitin-Proteasome System and Autophagy","volume":"42","author":"Kwon","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrm2780","article-title":"Building ubiquitin chains: E2 enzymes at work","volume":"10","author":"Ye","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.1158\/0008-5472.CAN-07-0568","article-title":"Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction","volume":"82","author":"Glickman","year":"2002","journal-title":"Physiol. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.7725097","article-title":"Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution","volume":"268","author":"Lowe","year":"1995","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2017.04.023","article-title":"The Logic of the 26S Proteasome","volume":"169","author":"Collins","year":"2017","journal-title":"Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.7732382","article-title":"Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin","volume":"268","author":"Fenteany","year":"1995","journal-title":"Science"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/oxfordjournals.jbchem.a021280","article-title":"Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine","volume":"119","author":"Tsubuki","year":"1996","journal-title":"J. Biochem."},{"key":"ref_62","first-page":"2638","article-title":"The proteasome inhibitor PS-341 in cancer therapy","volume":"5","author":"Teicher","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cbpa.2014.08.012","article-title":"Subunit specific inhibitors of proteasomes and their potential for immunomodulation","volume":"23","author":"Kisselev","year":"2014","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1158\/0008-5472.CAN-06-4086","article-title":"Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome","volume":"67","author":"Demo","year":"2007","journal-title":"Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.coi.2012.11.004","article-title":"The immunoproteasome in antigen processing and other immunological functions","volume":"25","author":"Basler","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.2174\/1381612811319220018","article-title":"Inhibitors of the immunoproteasome: Current status and future directions","volume":"19","author":"Miller","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.chembiol.2007.03.008","article-title":"LMP2-specific inhibitors: Chemical genetic tools for proteasome biology","volume":"14","author":"Ho","year":"2007","journal-title":"Chem. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm.1978","article-title":"A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis","volume":"15","author":"Muchamuel","year":"2009","journal-title":"Nat. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.molcel.2010.02.025","article-title":"Priming and extending: A UbcH5\/Cdc34 E2 handoff mechanism for polyubiquitination on a SCF substrate","volume":"37","author":"Wu","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S1097-2765(02)00783-9","article-title":"NEDD8 modification of CUL1 dissociates p120(CAND1), an inhibitor of CUL1-SKP1 binding and SCF ligases","volume":"10","author":"Liu","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature07884","article-title":"An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer","volume":"458","author":"Soucy","year":"2009","journal-title":"Nature"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrm3919","article-title":"Protein neddylation: Beyond cullin-RING ligases","volume":"16","author":"Enchev","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/s41467-017-01243-7","article-title":"A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation","volume":"8","author":"Zhou","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.cell.2011.05.039","article-title":"An allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme","volume":"145","author":"Ceccarelli","year":"2011","journal-title":"Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/geno.1995.1215","article-title":"Chromosomal localization and cDNA cloning of the genes (DDB1 and DDB2) for the p127 and p48 subunits of a human damage-specific DNA binding protein","volume":"29","author":"Dualan","year":"1995","journal-title":"Genomics"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"21293","DOI":"10.1016\/S0021-9258(19)36923-6","article-title":"Characterization of a human DNA damage binding protein implicated in xeroderma pigmentosum E","volume":"268","author":"Keeney","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"35309","DOI":"10.1074\/jbc.274.50.35309","article-title":"Cullin 4A associates with the UV-damaged DNA-binding protein DDB","volume":"274","author":"Shiyanov","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cell.2005.10.033","article-title":"Structure of DDB1 in complex with a paramyxovirus V protein: Viral hijack of a propeller cluster in ubiquitin ligase","volume":"124","author":"Li","year":"2006","journal-title":"Cell"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.cell.2006.09.045","article-title":"Deletion of DDB1 in mouse brain and lens leads to p53-dependent elimination of proliferating cells","volume":"127","author":"Cang","year":"2006","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1073\/pnas.0611311104","article-title":"DDB1 is essential for genomic stability in developing epidermis","volume":"104","author":"Cang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbrc.2007.10.063","article-title":"DDB1 gene disruption causes a severe growth defect and apoptosis in chicken DT40 cells","volume":"364","author":"Wakasugi","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nature05175","article-title":"Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery","volume":"443","author":"Angers","year":"2006","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.molcel.2011.08.025","article-title":"Systematic and quantitative assessment of the ubiquitin-modified proteome","volume":"44","author":"Kim","year":"2011","journal-title":"Mol. Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nsmb.1719","article-title":"A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery","volume":"17","author":"Li","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2011.09.019","article-title":"Global identification of modular cullin-RING ligase substrates","volume":"147","author":"Emanuele","year":"2011","journal-title":"Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4161\/cc.10.2.14530","article-title":"CRL4Cdt2: Master coordinator of cell cycle progression and genome stability","volume":"10","author":"Abbas","year":"2011","journal-title":"Cell Cycle"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"pe21","DOI":"10.1126\/stke.3352006pe21","article-title":"Viral modulators of cullin RING ubiquitin ligases: Culling the host defense","volume":"2006","author":"Barry","year":"2006","journal-title":"Sci. Stke"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/biom4040897","article-title":"Cullin E3 ligases and their rewiring by viral factors","volume":"4","author":"Mahon","year":"2014","journal-title":"Biomolecules"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/JVI.72.1.266-272.1998","article-title":"Hepatitis B virus X protein interferes with cellular DNA repair","volume":"72","author":"Becker","year":"1998","journal-title":"J. Virol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsiere","year":"2016","journal-title":"Nature"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","article-title":"Hepatitis B Virus X Protein Promotes Degradation of SMC5\/6 to Enhance HBV Replication","volume":"16","author":"Murphy","year":"2016","journal-title":"Cell Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/hep.25928","article-title":"Hepatitis B virus X protein stimulates gene expression selectively from extrachromosomal DNA templates","volume":"56","author":"Robert","year":"2012","journal-title":"Hepatology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"37333","DOI":"10.1074\/jbc.M110.133181","article-title":"HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation","volume":"285","author":"Ahn","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Belzile, J.P., Duisit, G., Rougeau, N., Mercier, J., Finzi, A., and Cohen, E.A. (2007). HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase. PLoS Pathog., 3.","DOI":"10.1371\/journal.ppat.0030085"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"11778","DOI":"10.1073\/pnas.0702102104","article-title":"Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle","volume":"104","author":"Hrecka","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Huang, C.Y., Chiang, S.F., Lin, T.Y., Chiou, S.H., and Chow, K.C. (2012). HIV-1 Vpr triggers mitochondrial destruction by impairing Mfn2-mediated ER-mitochondria interaction. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033657"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cell.2013.12.011","article-title":"Premature activation of the SLX4 complex by Vpr promotes G2\/M arrest and escape from innate immune sensing","volume":"156","author":"Laguette","year":"2014","journal-title":"Cell"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1073\/pnas.1600485113","article-title":"HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages","volume":"113","author":"Lahouassa","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1074\/jbc.M115.689018","article-title":"HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages","volume":"291","author":"Romani","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"17380","DOI":"10.1074\/jbc.M115.641522","article-title":"HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2\/M Cell Cycle Arrest","volume":"290","author":"Romani","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"10822","DOI":"10.1128\/JVI.01380-07","article-title":"DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest","volume":"81","author":"Tan","year":"2007","journal-title":"J. Virol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"15474","DOI":"10.1074\/jbc.M112.416735","article-title":"HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex","volume":"288","author":"Wang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"12550","DOI":"10.1074\/jbc.M112.340711","article-title":"HIV\/simian immunodeficiency virus (SIV) accessory virulence factor Vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4DCAF1","volume":"287","author":"Ahn","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature10195","article-title":"Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein","volume":"474","author":"Hrecka","year":"2011","journal-title":"Nature"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature10117","article-title":"SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx","volume":"474","author":"Laguette","year":"2011","journal-title":"Nature"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Sharova, N., Wu, Y., Zhu, X., Stranska, R., Kaushik, R., Sharkey, M., and Stevenson, M. (2008). Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.1000057"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Srivastava, S., Swanson, S.K., Manel, N., Florens, L., Washburn, M.P., and Skowronski, J. (2008). Lentiviral Vpx accessory factor targets VprBP\/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.1000059"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/JVI.02866-13","article-title":"Variation of two primate lineage-specific residues in human SAMHD1 confers resistance to N terminus-targeted SIV Vpx proteins","volume":"88","author":"Wei","year":"2014","journal-title":"J. Virol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/JVI.02568-13","article-title":"A first-in-class NAE inhibitor, MLN4924, blocks lentiviral infection in myeloid cells by disrupting neddylation-dependent Vpx-mediated SAMHD1 degradation","volume":"88","author":"Wei","year":"2014","journal-title":"J. Virol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"11379","DOI":"10.1128\/JVI.76.22.11379-11386.2002","article-title":"The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5","volume":"76","author":"Andrejeva","year":"2002","journal-title":"J. Virol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/viro.1998.9317","article-title":"The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein","volume":"249","author":"Lin","year":"1998","journal-title":"Virology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/viro.2002.1773","article-title":"Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components","volume":"304","author":"Ulane","year":"2002","journal-title":"Virology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e00773-18","DOI":"10.1128\/JVI.00773-18","article-title":"The Major Tegument Protein of Bovine Herpesvirus 1, VP8, Interacts with DNA Damage Response Proteins and Induces Apoptosis","volume":"92","author":"Afroz","year":"2018","journal-title":"J. Virol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.virusres.2012.04.005","article-title":"Bovine herpesvirus-1 VP8 interacts with DNA damage binding protein-1 (DDB1) and is monoubiquitinated during infection","volume":"167","author":"Vasilenko","year":"2012","journal-title":"Virus Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1128\/JVI.02732-05","article-title":"Deregulation of DNA damage signal transduction by herpesvirus latency-associated M2","volume":"80","author":"Liang","year":"2006","journal-title":"J. Virol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Trilling, M., Le, V.T., Fiedler, M., Zimmermann, A., Bleifuss, E., and Hengel, H. (2011). Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-gamma-stimulated cells. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002069"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3389\/fimmu.2018.02978","article-title":"A Mass Spectrometry-Based Profiling of Interactomes of Viral DDB1- and Cullin Ubiquitin Ligase-Binding Proteins Reveals NF-kappaB Inhibitory Activity of the HIV-2-Encoded Vpx","volume":"9","author":"Landsberg","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"19977","DOI":"10.1038\/srep19977","article-title":"Broad and potent antiviral activity of the NAE inhibitor MLN4924","volume":"6","author":"Megger","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1128\/JVI.05442-11","article-title":"Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response","volume":"86","author":"Salsman","year":"2012","journal-title":"J. Virol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chom.2018.07.011","article-title":"High-Definition Analysis of Host Protein Stability during Human Cytomegalovirus Infection Reveals Antiviral Factors and Viral Evasion Mechanisms","volume":"24","author":"Nightingale","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1128\/JVI.75.4.1697-1707.2001","article-title":"Murine cytomegalovirus open reading frame M27 plays an important role in growth and virulence in mice","volume":"75","author":"Abenes","year":"2001","journal-title":"J. Virol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/S1386-6532(02)00096-3","article-title":"Genetic analyses of gene function and pathogenesis of murine cytomegalovirus by transposon-mediated mutagenesis","volume":"25","author":"Lee","year":"2002","journal-title":"J. Clin. Virol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/viro.1999.0089","article-title":"Mutagenesis of murine cytomegalovirus using a Tn3-based transposon","volume":"266","author":"Zhan","year":"2000","journal-title":"Virology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/JVI.78.4.1831-1842.2004","article-title":"A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction","volume":"78","author":"Khan","year":"2004","journal-title":"J. Virol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1099\/vir.0.83538-0","article-title":"Mouse cytomegalovirus inhibits beta interferon (IFN-beta) gene expression and controls activation pathways of the IFN-beta enhanceosome","volume":"89","author":"Le","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"13638","DOI":"10.1128\/JVI.00216-14","article-title":"M27 expressed by cytomegalovirus counteracts effective type I interferon induction of myeloid cells but not of plasmacytoid dendritic cells","volume":"88","author":"Doring","year":"2014","journal-title":"J. Virol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1084\/jem.20011666","article-title":"Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo","volume":"195","author":"Barchet","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"13640","DOI":"10.1073\/pnas.0502883102","article-title":"Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1","volume":"102","author":"Unterstab","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.chom.2011.01.006","article-title":"Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest","volume":"9","author":"Reitsma","year":"2011","journal-title":"Cell Host Microbe"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1099\/vir.0.2008\/001669-0","article-title":"Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation","volume":"89","author":"Le","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1128\/JVI.77.14.7746-7755.2003","article-title":"Murine cytomegalovirus with a transposon insertional mutation at open reading frame M35 is defective in growth in vivo","volume":"77","author":"Tam","year":"2003","journal-title":"J. Virol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Chan, B., Goncalves Magalhaes, V., Lemmermann, N.A.W., Juranic Lisnic, V., Stempel, M., Bussey, K.A., Reimer, E., Podlech, J., Lienenklaus, S., and Reddehase, M.J. (2017). The murine cytomegalovirus M35 protein antagonizes type I IFN induction downstream of pattern recognition receptors by targeting NF-kappaB mediated transcription. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006382"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/jvi.76.5.2460-2468.2002","article-title":"The human cytomegalovirus UL35 gene encodes two proteins with different functions","volume":"76","author":"Liu","year":"2002","journal-title":"J. Virol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1128\/JVI.79.5.3084-3096.2005","article-title":"Human cytomegalovirus tegument protein ppUL35 is important for viral replication and particle formation","volume":"79","author":"Schierling","year":"2005","journal-title":"J. Virol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"9512","DOI":"10.1128\/JVI.78.17.9512-9523.2004","article-title":"Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer","volume":"78","author":"Schierling","year":"2004","journal-title":"J. Virol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"9575","DOI":"10.1073\/pnas.1207496109","article-title":"BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection","volume":"109","author":"Lee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.virol.2011.03.013","article-title":"Nuclear body formation and PML body remodeling by the human cytomegalovirus protein UL35","volume":"414","author":"Salsman","year":"2011","journal-title":"Virology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e00013-18","DOI":"10.1128\/JVI.00013-18","article-title":"Interaction of Human Cytomegalovirus Tegument Proteins ppUL35 and ppUL35A with Sorting Nexin 5 Regulates Glycoprotein B (gpUL55) Localization","volume":"92","author":"Maschkowitz","year":"2018","journal-title":"J. Virol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s12038-007-0112-2","article-title":"Human cytomegalovirus UL145 gene is highly conserved among clinical strains","volume":"32","author":"Sun","year":"2007","journal-title":"J. Biosci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"CR423","DOI":"10.12659\/MSM.881903","article-title":"Characterization of human cytomegalovirus UL145 and UL136 genes in low-passage clinical isolates from infected Chinese infants","volume":"17","author":"Wang","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/jmv.22241","article-title":"Transcriptional features and transcript structure of UL145 in different strains of human cytomegalovirus","volume":"83","author":"Wang","year":"2011","journal-title":"J. Med. Virol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1348-0421.2010.00294.x","article-title":"Characterization of 3\u2032 termini of human cytomegalovirus UL138-UL145 transcripts in a clinical strain","volume":"55","author":"Qi","year":"2011","journal-title":"Microbiol. Immunol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"12411","DOI":"10.1073\/pnas.0805685105","article-title":"Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH prevents genomic instability from stalled replication forks","volume":"105","author":"Motegi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1073\/pnas.0800563105","article-title":"Human HLTF functions as a ubiquitin ligase for proliferating cell nuclear antigen polyubiquitination","volume":"105","author":"Unk","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"14073","DOI":"10.1073\/pnas.1101951108","article-title":"Coordinated protein and DNA remodeling by human HLTF on stalled replication fork","volume":"108","author":"Achar","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/MCB.00863-09","article-title":"Role of double-stranded DNA translocase activity of human HLTF in replication of damaged DNA","volume":"30","author":"Blastyak","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/dna.1996.15.429","article-title":"Characterization of a helicase-like transcription factor involved in the expression of the human plasminogen activator inhibitor-1 gene","volume":"15","author":"Ding","year":"1996","journal-title":"DNA Cell Biol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/blood.V99.1.348","article-title":"DNA-dependent adenosine triphosphatase (helicaselike transcription factor) activates beta-globin transcription in K562 cells","volume":"99","author":"Mahajan","year":"2002","journal-title":"Blood"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fmicb.2013.00051","article-title":"Data-warehousing of protein-protein interactions indicates that pathogens preferentially target hub and bottleneck proteins","volume":"4","author":"Schleker","year":"2013","journal-title":"Front. Microbiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.febslet.2008.01.040","article-title":"Proteasome inhibitor MG132 blocks viral DNA replication and assembly of human cytomegalovirus","volume":"582","author":"Kaspari","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/135965350300800608","article-title":"Proteasome inhibitors: A novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation","volume":"8","author":"Prosch","year":"2003","journal-title":"Antivir. Ther."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1128\/JVI.02236-09","article-title":"Proteasome subunits relocalize during human cytomegalovirus infection, and proteasome activity is necessary for efficient viral gene transcription","volume":"84","author":"Tran","year":"2010","journal-title":"J. Virol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1634\/theoncologist.8-6-508","article-title":"Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy","volume":"8","author":"Kane","year":"2003","journal-title":"Oncologist"},{"key":"ref_154","first-page":"303","article-title":"Carfilzomib (Kyprolis): A Novel Proteasome Inhibitor for Relapsed and\/or Refractory Multiple Myeloma","volume":"41","author":"Perel","year":"2016","journal-title":"Pharm. Ther."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.4049\/jimmunol.0901596","article-title":"The proteasome inhibitor bortezomib enhances the susceptibility to viral infection","volume":"183","author":"Basler","year":"2009","journal-title":"J. Immunol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"7880","DOI":"10.1128\/JVI.00486-10","article-title":"The proteasome inhibitor Velcade enhances rather than reduces disease in mouse hepatitis coronavirus-infected mice","volume":"84","author":"Raaben","year":"2010","journal-title":"J. Virol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3816\/CLM.2008.n.031","article-title":"Bortezomib and the increased incidence of herpes zoster in patients with multiple myeloma","volume":"8","author":"Kim","year":"2008","journal-title":"Clin. Lymphoma Myeloma"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/tid.12162","article-title":"High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: A survey from the Rome transplant network","volume":"16","author":"Marchesi","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1182\/blood-2009-11-254862","article-title":"Inhibition of NEDD8-activating enzyme: A novel approach for the treatment of acute myeloid leukemia","volume":"115","author":"Swords","year":"2010","journal-title":"Blood"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/1078-0432.CCR-15-1237","article-title":"Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed\/Refractory Multiple Myeloma or Lymphoma","volume":"22","author":"Shah","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1742-4690-10-138","article-title":"HIV relies on neddylation for ubiquitin ligase-mediated functions","volume":"10","author":"Nekorchuk","year":"2013","journal-title":"Retrovirology"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Mudhasani, R., Tran, J.P., Retterer, C., Kota, K.P., Whitehouse, C.A., and Bavari, S. (2016). Protein Kinase R Degradation Is Essential for Rift Valley Fever Virus Infection and Is Regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 Ligase. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005437"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.virol.2017.11.004","article-title":"Inhibition of neddylation pathway represses influenza virus replication and pro-inflammatory responses","volume":"514","author":"Sun","year":"2018","journal-title":"Virology"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e00505-17","DOI":"10.1128\/JVI.00505-17","article-title":"Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi\u2019s Sarcoma-Associated Herpesvirus","volume":"91","author":"Chang","year":"2017","journal-title":"J. Virol."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Hughes, D.J., Wood, J.J., Jackson, B.R., Baquero-Perez, B., and Whitehouse, A. (2015). NEDDylation is essential for Kaposi\u2019s sarcoma-associated herpesvirus latency and lytic reactivation and represents a novel anti-KSHV target. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004771"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Sekiba, K., Otsuka, M., Ohno, M., Yamagami, M., Kishikawa, T., Seimiya, T., Suzuki, T., Tanaka, E., Ishibashi, R., and Funato, K. (2018). Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, is a potent inhibitor of hepatitis B virus. Hepatology.","DOI":"10.1016\/S0016-5085(19)39962-7"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/BJ20141450","article-title":"Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: Structure, assembly and small-molecule modulation","volume":"467","author":"Bulatov","year":"2015","journal-title":"Biochem. J."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.chembiol.2018.10.022","article-title":"From Discovery to Bedside: Targeting the Ubiquitin System","volume":"26","author":"Wertz","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1126\/science.1160489","article-title":"Global protein stability profiling in mammalian cells","volume":"322","author":"Yen","year":"2008","journal-title":"Science"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1021\/pr700749v","article-title":"A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins","volume":"7","author":"Jones","year":"2008","journal-title":"J. Proteome Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cell.2004.06.016","article-title":"Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity","volume":"118","author":"Xirodimas","year":"2004","journal-title":"Cell"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/embor.2008.10","article-title":"Ribosomal proteins are targets for the NEDD8 pathway","volume":"9","author":"Xirodimas","year":"2008","journal-title":"EMBO Rep."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nbt.1645","article-title":"Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase","volume":"28","author":"Aghajan","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcmgh.2018.10.010","article-title":"Inhibition of HBV Transcription From cccDNA with Nitazoxanide by Targeting the HBx-DDB1 Interaction","volume":"7","author":"Sekiba","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.chom.2015.03.004","article-title":"Molecular determinants for recognition of divergent SAMHD1 proteins by the lentiviral accessory protein Vpx","volume":"17","author":"Schwefel","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature12815","article-title":"Structural basis of lentiviral subversion of a cellular protein degradation pathway","volume":"505","author":"Schwefel","year":"2014","journal-title":"Nature"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/7\/1636\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:42:18Z","timestamp":1760186538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/7\/1636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":176,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,4]]}},"alternative-id":["ijms20071636"],"URL":"https:\/\/doi.org\/10.3390\/ijms20071636","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,2]]}}}